Table 2.
Demographic characteristics of TIN cases associated with statin use (2017–2019 vs. 2020–2024).
| Variable | Category | 2017–2019 (n %) | 2020–2024 (n %) |
|---|---|---|---|
| Sex | Female | 3 (18.8) | 57 (54.8) |
| Male | 12 (75.0) | 32 (30.8) | |
| Unknown | 1 (6.3) | 15 (14.4) | |
| Age group | 0–17 | 0 (0.0) | 1 (1.0) |
| 18–40 | 0 (0.0) | 9 (8.7) | |
| 41–60 | 4 (25.0) | 6 (5.8) | |
| 61–90 | 10 (62.5) | 72 (69.2) | |
| ≥90 | 1 (6.3) | 1 (1.0) | |
| Reporter occupation | Unknown | 2 (12.5) | 2 (1.9) |
| Physician (MD) | 5 (31.3) | 41 (39.4) | |
| Other Healthcare professionals | 7 (43.8) | 45 (43.3) | |
| Pharmacist | 2 (12.5) | 16 (15.4) |